RoACTEMRA

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug RoACTEMRA contains one active pharmaceutical ingredient (API):

1 Tocilizumab UNII I031V2H011 - TOCILIZUMAB

Tocilizumab binds specifically to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R). IL-6 is involved in diverse physiological processes such as T-cell activation, induction of immunoglobulin secretion, induction of hepatic acute phase protein synthesis and stimulation of haemopoiesis. IL-6 has been implicated in the pathogenesis of diseases including inflammatory diseases, osteoporosis and neoplasia. Read about Tocilizumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RoACTEMRA Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC
RoACTEMRA Solution for injection in pre-filled syringe	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AC07	Tocilizumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1399125, 1399136, 1399147, 1399158, 1399169, 1399170, 1647200, 1693874, 1769823, 1769834
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08492001, 08492003, 108492007, 108492009
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 063926, 115769, 170062, 170085, 170107
Country: FR	Base de données publique des médicaments	Identifier(s): 67121308, 69107620, 69582503
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 160992, 160995, 160998, 247809, 354107
Country: IE	Health Products Regulatory Authority	Identifier(s): 88456, 88964
Country: IT	Agenzia del Farmaco	Identifier(s): 038937013, 038937025, 038937037, 038937049, 038937052, 038937064, 038937088, 038937090, 038937102, 038937114
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1035997, 1035998, 1035999, 1036000, 1036001, 1036002, 1073927, 1076160, 1086244, 1086245
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 116475, 150703, 88994, 89001
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100203645, 100309763
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64403001, W64403002, W64403003, W64403004, W64403005, W64403006, W64404001